....Then there is the Hervaxx phase 2 results and PD1 phase 1 results, but I'm not sure if these have been priced in by the market already they might need to be over and above what we have already seen from the interim results to get the price moving again dramatically??...
Hi morning @dappaT
Always enjoy and appreciate your TA!
However, I’m not sure if you had watched the ASX CEO/Leslie Chong interview video dated 29 June 2021 when you scripted your FA commentary above.
@ 8.50minute, Leslie said a trial lung cancer patient ( I presume he she would be at Stage 3 or very late stage ), went home and told the family something like “I’m cancer free now. For 150 days...“
This is his her 3rd or 4th chance of life ! Personally I would consider this as super news , way over and above the main purpose of PD1 Phase 1 trial which is primarily for dosage safety study.
TheASXCEOinterviewisbyfartheBESTIhavewatched. Leslie said, “ she’s thrilled, excited, and over the moon. “ and rightfully she should be.
And, me too !
the low volume is due to investors don’t want to off load their shares cheap !
IMUGENE CHART. TA only, page-3472
-
- There are more pages in this discussion • 30,993 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 3441484 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 574188 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 2626814 | 0.054 |
21 | 3124322 | 0.053 |
28 | 4941821 | 0.052 |
31 | 3703294 | 0.051 |
70 | 6394327 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 401800 | 3 |
0.056 | 100000 | 1 |
0.057 | 444535 | 7 |
0.058 | 400000 | 2 |
0.059 | 350000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |